SCHEMBL4765995

SCHEMBL4765995

CCN1CCN(c2nc(-c3ccc(CN4CCOCC4)cc3)cc3ccccc23)CC1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ACP1 P24666 3/20 0.48
HRH3 Q9Y5N1 1/20 0.45
LMNA P02545 3/20 0.45
MAPT P10636 2/20 0.45
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
HPGD P15428 1/20 0.45
ACHE P22303 1/20 0.44
CSF1R P07333 1/20 0.44
PIK3CD O00329 1/20 0.44
MOK Q9UQ07 2/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
ATM Q13315 1/20 0.43
JAK2 O60674 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
SYK P43405 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4766949 0.99 ACP1 (0.47) ACP1HRH3LMNAMAPTKDM4E
SCHEMBL4773119 0.88 AHR (0.54) LMNAMAPTKDM4EALDH1A1HPGD
SCHEMBL4769939 0.88 LMNA (0.45) ACP1LMNAMAPTKDM4EALDH1A1
Hydrochloric Acid SCHEMBL4770492 0.87 MAPT (0.55) LMNAMAPTKDM4EALDH1A1HPGD
Hydrochloric Acid SCHEMBL4766893 0.87 LMNA (0.44) ACP1LMNAMAPTKDM4EALDH1A1
SCHEMBL4773150 0.85 ACP1 (0.46) ACP1LMNAMAPTPIK3CDSMN1; SMN2
Hydrochloric Acid SCHEMBL4765382 0.84 ACP1 (0.45) ACP1LMNAMAPTKDM4EALDH1A1
SCHEMBL4766408 0.84 SMN1; SMN2 (0.46) HRH3LMNAMAPTALDH1A1HPGD
SCHEMBL4765992 0.83 PIK3CD (0.51) LMNAMAPTKDM4EALDH1A1PIK3CD
Hydrochloric Acid SCHEMBL4773469 0.83 SMN1; SMN2 (0.45) LMNAMAPTKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020013460-A1 Condensed pyridine compound EISAI CO., LTD 2002-01-31 US claimed
EP-1020445-A1 FUSED PYRIDINE DERIVATIVES Eisai Co., Ltd. (JP) 2000-07-19 EP claimed
EP-1020445-B1 FUSED PYRIDINE DERIVATIVES EISAI R&D MAN CO LTD (JP) 2008-08-13 EP disclosed
EP-1020445-B1 FUSED PYRIDINE DERIVATIVES EISAI R&D MAN CO LTD (JP) 2008-08-13 EP disclosed
US-20040204421-A1 Certain 1,3-disubstituted isoquinoline derivatives EISAI CO., LTD. 2004-10-14 US disclosed
US-6790844-B2 MUSCLE RELAXANTS; ANTISEROTONINE AGENT EISAI CO., LTD (JP) 2004-09-14 US disclosed
US-20020013460-A1 Condensed pyridine compound EISAI CO., LTD 2002-01-31 US disclosed
US-6340759-B1 ANTISPASMODIC AGENTS EISAI CO., LTD. (JP) 2002-01-22 US disclosed
EP-1020445-A1 FUSED PYRIDINE DERIVATIVES Eisai Co., Ltd. (JP) 2000-07-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020013460-A1 Condensed pyridine compound MUSK, HTR1A, PAX3 ACP1 4287/4885HRH3 191/4885LMNA 1057/4885
US-20040204421-A1 Certain 1,3-disubstituted isoquinoline derivatives MUSK, HTR1A, RYR1 ACP1 4323/4885HRH3 110/4885LMNA 1917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.